Cadence Pharmaceuticals (Nasdaq: CADX) Stock Climbs 26% in Latest Biotech … – Money Morning

Drug Discovery & Development

Cadence Pharmaceuticals (Nasdaq: CADX) Stock Climbs 26% in Latest Biotech … Money Morning Another consolidation in the active biotech sector came Tuesday when Cadence Pharmaceuticals Inc. (Nasdaq: CADX) agreed to be acquired by Mallinckrodt plc (NYSE: MNK) in a $ 1.3 billion deal. The move sent CADX up 26%. Under terms of the deal, … Sector Update: HealthcareNASDAQ Cadence Pharmaceuticals, Inc. (NASDAQ:CADX) Takeover Price Signals 27 Pc …WallStreetPR Mid Day Recap: Cadence Pharmaceuticals, Inc. (NASDAQ:CADX), Hansen …Market News Call all 155 news articles »

nasdaq – Google News